Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 15 04:00PM ET
2.50
Dollar change
-0.24
Percentage change
-8.76
%
Index- P/E- EPS (ttm)-2.82 Insider Own40.22% Shs Outstand29.74M Perf Week-16.94%
Market Cap74.42M Forward P/E- EPS next Y-2.69 Insider Trans-2.61% Shs Float17.80M Perf Month-17.76%
Income-64.73M PEG- EPS next Q-0.62 Inst Own54.87% Short Float1.53% Perf Quarter-88.03%
Sales0.00M P/S- EPS this Y-1.02% Inst Trans0.77% Short Ratio0.57 Perf Half Y-83.05%
Book/sh4.19 P/B0.60 EPS next Y2.82% ROA-53.65% Short Interest0.27M Perf Year-71.91%
Cash/sh3.60 P/C0.69 EPS next 5Y- ROE-58.83% 52W Range2.72 - 22.22 Perf YTD-87.80%
Dividend Est.- P/FCF- EPS past 5Y-73.03% ROI-51.91% 52W High-88.75% Beta-0.16
Dividend TTM- Quick Ratio7.87 Sales past 5Y0.00% Gross Margin- 52W Low-8.09% ATR (14)0.32
Dividend Ex-DateApr 12, 2018 Current Ratio7.87 EPS Y/Y TTM-26.91% Oper. Margin0.00% RSI (14)24.38 Volatility8.40% 7.71%
Employees41 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom2.20 Target Price6.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q6.88% Payout- Rel Volume0.40 Prev Close2.74
Sales Surprise- EPS Surprise22.55% Sales Q/Q- EarningsMar 28 AMC Avg Volume482.02K Price2.50
SMA20-21.01% SMA50-55.32% SMA200-79.90% Trades Volume190,571 Change-8.76%
Date Action Analyst Rating Change Price Target Change
Apr-02-24Upgrade JMP Securities Mkt Perform → Mkt Outperform $6
Feb-13-24Downgrade Leerink Partners Outperform → Market Perform $23 → $7
Feb-12-24Downgrade Oppenheimer Outperform → Perform
Feb-12-24Downgrade JMP Securities Mkt Outperform → Mkt Perform
Feb-12-24Downgrade Evercore ISI Outperform → In-line $25 → $7
Jan-04-24Initiated JMP Securities Mkt Outperform $30
Jul-18-22Resumed Oppenheimer Outperform $22
Mar-28-24 11:53PM
04:10PM
Mar-22-24 07:00AM
Feb-22-24 04:21AM
Feb-12-24 10:03AM
07:04AM Loading…
07:04AM
06:54AM
06:45AM
Jan-30-24 04:10PM
Jan-12-24 03:02AM
Jan-10-24 08:50AM
Nov-09-23 04:05PM
Nov-06-23 08:50AM
07:00AM
Oct-18-23 07:00AM
12:01AM Loading…
Oct-11-23 12:01AM
Sep-27-23 09:40AM
Sep-26-23 07:00AM
Sep-13-23 07:00AM
Sep-11-23 09:40AM
Aug-15-23 10:42PM
Aug-10-23 04:10PM
Jun-14-23 08:55AM
May-25-23 04:10PM
May-18-23 07:00AM
May-11-23 04:10PM
May-09-23 06:05AM
May-01-23 07:00AM
Mar-29-23 04:01PM
Feb-28-23 04:10PM
04:10PM Loading…
Jan-31-23 04:10PM
Dec-04-22 08:40AM
Nov-09-22 04:05PM
Nov-02-22 04:10PM
Oct-19-22 08:00AM
Oct-06-22 07:00AM
Sep-29-22 07:00AM
Aug-29-22 07:00AM
Aug-11-22 04:10PM
Aug-08-22 11:42AM
Jul-01-22 10:39AM
Jun-29-22 07:00AM
Jun-27-22 09:19AM
May-10-22 04:10PM
May-09-22 07:00AM
Apr-18-22 09:30AM
Mar-28-22 10:33AM
Mar-25-22 04:40PM
03:06PM
Mar-24-22 10:32PM
02:11PM
AN2 Therapeutics, Inc. operates as a global health biopharmaceutical company. The firm focuses on modern biomedical and drug development to provide transformational medicines for patients suffering from infectious diseases. The company was founded by Eric Easom, George Harrison Talbot, Joseph S. Zakrzewski and Michael R.K. Alley and is headquartered in Menlo Park, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Zakrzewski Joseph SDirectorJan 18 '24Sale19.11100,0001,911,410405,880Jan 19 07:32 PM
Aziz KabeerDirectorJan 16 '24Sale19.65100,0001,965,000377,542Jan 18 06:19 PM
Adjuvant Global Health Technol10% OwnerJan 16 '24Sale19.6584,0931,652,4271,995,958Jan 18 06:18 PM
Adjuvant Global Health Technol10% OwnerJan 16 '24Sale19.6515,907312,573377,542Jan 18 06:18 PM
Readnour Robin ShaneDirectorJan 12 '24Sale21.911,42531,229414,788Jan 17 05:03 PM
Readnour Robin ShaneDirectorJan 10 '24Sale21.933,66980,443415,494Jan 12 05:08 PM
Krause Kevin MichaelChief Strategy OfficerJan 09 '24Option Exercise4.597,41734,0159,331Jan 11 07:59 PM
Krause Kevin MichaelChief Strategy OfficerJan 09 '24Sale20.147,417149,3671,914Jan 11 07:59 PM
Krause Kevin MichaelChief Strategy OfficerJan 02 '24Option Exercise0.422,5831,0854,497Jan 04 06:06 PM
Easom EricChief Executive OfficerJan 02 '24Sale20.092,77755,8022,130Jan 04 06:05 PM
Krause Kevin MichaelChief Strategy OfficerJan 02 '24Sale20.122,58351,9671,914Jan 04 06:06 PM
Aziz KabeerDirectorNov 14 '23Sale16.151,81029,224393,449Nov 16 06:57 PM
Adjuvant Global Health Technol10% OwnerNov 14 '23Sale16.151,52224,5742,080,051Nov 16 06:59 PM
Adjuvant Global Health Technol10% OwnerNov 14 '23Sale16.152884,650393,449Nov 16 06:59 PM
Aziz KabeerDirectorOct 02 '23Sale16.075,67291,149393,737Oct 03 07:21 PM
Adjuvant Global Health Technol10% OwnerOct 02 '23Sale16.074,77076,6542,081,573Oct 03 07:13 PM
Adjuvant Global Health Technol10% OwnerOct 02 '23Sale16.0790214,495393,737Oct 03 07:13 PM
Aziz KabeerDirectorSep 29 '23Sale16.2899,1011,613,364394,639Oct 03 07:21 PM
Adjuvant Global Health Technol10% OwnerSep 29 '23Sale16.2883,3371,356,7262,086,343Oct 03 07:13 PM
Adjuvant Global Health Technol10% OwnerSep 29 '23Sale16.2815,764256,638394,639Oct 03 07:13 PM
Aziz KabeerDirectorSep 28 '23Sale16.118,516137,193410,403Sep 29 05:40 PM
Adjuvant Global Health Technol10% OwnerSep 28 '23Sale16.117,160115,3482,169,680Sep 29 05:41 PM
Adjuvant Global Health Technol10% OwnerSep 28 '23Sale16.111,35621,845410,403Sep 29 05:41 PM
Aziz KabeerDirectorSep 27 '23Sale16.0784113,515411,759Sep 29 05:40 PM
Adjuvant Global Health Technol10% OwnerSep 27 '23Sale16.0770711,3612,176,840Sep 29 05:41 PM
Adjuvant Global Health Technol10% OwnerSep 27 '23Sale16.071342,153411,759Sep 29 05:41 PM
Aziz KabeerDirectorSep 13 '23Sale16.004006,400411,893Sep 15 05:40 PM
Adjuvant Global Health Technol10% OwnerSep 13 '23Sale16.003365,3762,177,547Sep 15 05:17 PM
Adjuvant Global Health Technol10% OwnerSep 13 '23Sale16.00641,024411,893Sep 15 05:17 PM
Aziz KabeerDirectorSep 07 '23Sale16.053,37854,217411,957Sep 08 04:57 PM
Adjuvant Global Health Technol10% OwnerSep 07 '23Sale16.052,84145,5982,177,883Sep 08 04:59 PM
Adjuvant Global Health Technol10% OwnerSep 07 '23Sale16.055378,619411,957Sep 08 04:59 PM
Aziz KabeerDirectorSep 06 '23Sale16.023,76260,267412,494Sep 08 04:57 PM
Adjuvant Global Health Technol10% OwnerSep 06 '23Sale16.023,16450,6872,180,724Sep 08 04:59 PM
Adjuvant Global Health Technol10% OwnerSep 06 '23Sale16.025989,580412,494Sep 08 04:59 PM
Aziz KabeerDirectorAug 23 '23Sale16.004006,400413,092Aug 25 04:30 PM
Adjuvant Global Health Technol10% OwnerAug 23 '23Sale16.003365,3762,183,888Aug 25 04:31 PM
Adjuvant Global Health Technol10% OwnerAug 23 '23Sale16.00641,024413,092Aug 25 04:31 PM
RA CAPITAL MANAGEMENT, L.P.10% OwnerAug 18 '23Buy9.001,777,77816,000,0025,135,683Aug 22 05:01 PM
Easom EricChief Executive OfficerMay 15 '23Buy5.3810,00053,7701,015,766May 15 08:01 PM